Sundia MediTech Rides WuXi IPO to Series B Funding
publication date: Jan 18, 2008
Sundia MediTech Company, a Shanghai-based CRO, has completed its second round of capital funding, though the amount raised was not disclosed. Sundia said that the fund raising has been underway since last summer, about the time that WuXi PharmaTech made its IPO on the NYSE. Company officials said that the success of the WuXi offering helped Sundia in its efforts. It also didn’t hurt that, last summer, Sundia was also ranked as number 16 on the Venture 50 list, a ranking of the most promising investment opportunities in China put together by investment house Zero2IPO. More details...
Stock Symbol: (NYSE: WX)
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.